Please provide your email address to receive an email when new articles are posted on . PARIS — Alcon announced the launch of its new AcrySert C preloaded IOL injector at a company-sponsored media ...
Basel, Switzerland, July 1, 2015 – Alcon, the global leader in eye care and a division of Novartis, has received European CE Mark for its AcrySof® IQ Aspheric IOL with the UltraSert™ Pre-loaded ...
IOLs and their respective materials and designs are intended to be inert and made in a way so that they are easy to handle concerning the folding-unfolding aspect and implantation into the eye. The ...
Alcon ALC recently launched its Clareon family of intraocular lenses (IOLs) in the United States. Based on Alcon’s advanced IOL material, Clareon claims to deliver better visual outcomes with ...
“As the global leader in eye care, we are committed to improving our technologies to advance patient outcomes through rigorous, world-class R&D—even with our leading products like PanOptix,” said Rob ...
Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced its plans to lead a wide-range of informational and peer-to-peer educational programs at the American ...
TORONTO--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of Clareon® PanOptix® Pro intraocular lens ...
The FINANCIAL — Alcon, one of the global leaders in eye care and a division of Novartis, has received US Food and Drug Administration (FDA) approval for its AcrySof IQ Aspheric IOL with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results